Company intelligence / Profile preview

Impel Capital

Washington, District of Columbia, United States

Ownership: Private
Development stage: Other

Overview

Impel Capital is a private investment firm focused on providing flexible capital solutions to lower middle market companies in the United States. The firm partners with founders, sponsors, and independent sponsors on buyout and growth transactions, investing across the capital structure through private credit and equity. Its stated sector focus includes industrials, business services, consumer services, and selected healthcare services rather than biotechnology or therapeutics development. Based on the available public information, Impel Capital is not a life sciences operating company, drug developer, or healthcare products business.

Industry: Investors

Beyond the preview

Go deeper on Impel Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Impel Capital.

Explore the full profile